Z116334910
Z116334910 is a promising WDR5-MLL1 interaction disruptor. Z116334910 can be used for the study of cancer[1].
Product Specifications
CAS Number
412940-42-2
Target
Others
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Purity
99.32
Solubility
DMSO : 5.83 mg/mL (ultrasonic)
Smiles
[O-][N+](C1=CC=CC(NC(C2=CC=C(C)C(S(=O)(N)=O)=C2)=O)=C1)=O
Molecular Formula
C14H13N3O5S
Molecular Weight
335.34
References & Citations
[1]Abuelrub A, et al. A Novel Multi-Tiered Hybrid Virtual Screening Pipeline for the Discovery of WDR5-MLL1 Interaction Disruptors in Precision Cancer Therapy. ACS Omega. 2025 Sep 29;10 (40) :46501-46523.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP721642 10 µg
GPR158 Human Recombinant Protein, Synthetic Nanodisc
Sign In for Pricing
View Details 
46190061 1.0 µg DNA
TAS2R37 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details MBS6242337-01 0.1 mL
Tenascin (Cytotactin, Tenascin C, Glioma associated Extracellular Matrix Antigen, GMEM, Hexabrachion) (APC)
Sign In for Pricing
View Details MBS6242337-02 5x 0.1 mL
Tenascin (Cytotactin, Tenascin C, Glioma associated Extracellular Matrix Antigen, GMEM, Hexabrachion) (APC)
Sign In for Pricing
View Details